| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $69.3M | +18.6% |
| Gross Profit | $46.5M | +15.9% |
| R&D Expense | $8.8M | -8.4% |
| SG&A Expense | $14.7M | -1.1% |
| Operating Income | -$34.1M | +22.6% |
| Pre-tax Income | -$38.0M | +18.6% |
| Income Tax | -$144K | — |
| Net Income | -$37.8M | +18.9% |
| EPS (Basic) | -$1.33 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $52.7M | +12.7% |
| Accounts Receivable | $10.1M | +3.7% |
| Inventory | $12.8M | -2.9% |
| Current Assets | $78.1M | +8.8% |
| Total Assets | $86.6M | +10.9% |
| Current Liabilities | $15.6M | -8.1% |
| Long-term Debt | $41.1M | +1.5% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$41.6M | -1.8% |
| Capital Expenditures | $989K | +61.9% |
| Investing Cash Flow | $4.5M | +843.1% |
| Financing Cash Flow | $43.1M | -6.9% |
| Free Cash Flow | -$42.6M | -2.7% |
| +34.8% |
| EPS (Diluted) | -$1.33 | +34.8% |
| Total Liabilities |
| $58.1M |
| -1.8% |
| Stockholders' Equity | $28.5M | +50.7% |